| Not yet recruiting | 3 | 250 | Europe, RoW | CBD 100 mg/mL Oral Solution, Placebo | University of Oxford, Wellcome Trust, GW Pharmaceuticals Ltd, Myonex, Cambridge Cognition Ltd, Premier Research Group plc, Diagram B.V., Cambridgeshire and Peterborough NHS Foundation Trust, Oxford Health NHS Foundation Trust, West London NHS Trust, University of Augsburg, Charite University, Berlin, Germany, University of Cologne, Ludwig Maximilian university of Munich, The Sheba Fund for Health Services and Research, Shalvata Mental Health Center, Geha Mental Health Center, Amsterdam University Medical Center, Hospital General Universitario Gregorio Marañon, National and Kapodistrian University of Athens, Medical University of Vienna, Hospitales Universitarios Virgen del Rocío, University of Campania Luigi Vanvitelli, Swansea University, Psychiatric University Hospital, Zurich, IDEA Regulatory | Psychosis, First Episode Psychosis, Psychotic Disorders, Psychotic Episode | 12/27 | 12/28 | | |
